Table 2.
Variables | HR (95% CI) | p Value |
---|---|---|
Demographic characteristics | ||
Age, years | 0.97 (0.97–0.98) | <0.001 |
Education, years | 0.88 (0.87–0.90) | <0.001 |
Current residence with family member(s) (no vs. yes) | 0.25 (0.22–0.29) | <0.001 |
Marital status (unmarried vs. married) | 0.47 (0.44–0.51) | <0.001 |
Body mass index, kg/m2 | 0.95 (0.94–0.95) | <0.001 |
Charlson Comorbidity Index, score | 0.62 (0.57–0.68) | <0.001 |
Tumor size, cm | 0.66 (0.62–0.70) | <0.001 |
Tumor stage | ||
I vs. 0 | 0.19 (0.15–0.26) | < 0.001 |
II vs. 0 | 0.19 (0.15–0.24) | <0.001 |
≥III vs. 0 | 0.47 (0.36–0.62) | <0.001 |
Smoker (no vs. yes) | 0.46 (0.26–0.81) | 0.007 |
Drinker (no vs. yes) | 0.11 (0.34–0.37) | <0.001 |
Breast cancer history (no vs. yes) | 0.34 (0.24–0.49) | <0.001 |
Clinical characteristics | ||
Surgery type | ||
BCS | 0.31 (0.16–0.63) | <0.001 |
MRM | 2.00 (1.47–2.73) | <0.001 |
Mastectomy with reconstruction | 0.75 (0.56–1.00) | 0.050 |
ASA score | 0.50 (0.47–0.54) | <0.001 |
Chemotherapy (no vs. yes) | 0.28 (0.24–0.33) | <0.001 |
Radiotherapy (no vs. yes) | 0.28 (0.23–0.33) | <0.001 |
Hormonal therapy (no vs. yes) | 0.24 (0.20–0.30) | <0.001 |
Surgeon volume (medium vs. low) | 0.98 (0.98–0.99) | <0.001 |
Surgeon volume (high vs. low) | 0.97 (0.97–0.98) | <0.001 |
Hospital volume (medium vs. low) | 0.98 (0.98–0.99) | <0.001 |
Hospital volume (high vs. low) | 0.97 (0.97–0.98) | <0.001 |
Quality of care within 10 years | ||
Readmission in 30 days (no vs. yes) | 0.23 (0.17–0.31) | <0.001 |
Postoperative reconstruction (no vs. yes) | 0.50 (0.35–0.72) | <0.001 |
Preoperative quality of life | ||
Preoperative SF36 PCS score | 0.97 (0.96–0.97) | <0.001 |
Preoperative SF36 MCS score | 0.98 (0.97–0.98) | <0.001 |
HR: hazards ratio; BCS: breast conserving surgery; MRM: modified radical mastectomy; ASA: American Society of Anesthesiologists; PCS: physical component summary; MCS: mental component summary.